CRISPR isn't the end of the story for gene editing

April 15, 2026 | 11:00 AM – 1:00 PM ET | Boston + Hybrid

CRISPR rewrote what was possible in gene editing. A decade in, scientists are back at the drawing board hunting for the next big editing tool — and the field is wide open.

At Drug Discovery Day, researchers working on the newest technologies unpack what role CRISPR still has to play and where gene editing goes from here.

Drug Discovery Day starts with free virtual programming in the morning, followed by a ticketed happy hour and fireside chat at Row 34 in Cambridge. Virtual is free to all with registration. Only a few Happy Hour tickets remain.

Join us

Register for free

Get your Happy Hour ticket

Row 34, Cambridge, MA

What's on the agenda?

AM: How do you turn fragmented R&D data into a real competitive advantage — and make smarter commercialization decisions before it's too late?
PM: CRISPR has gone from breakthrough science to real therapeutic programs — and Aurora Therapeutics is pushing it further. CEO Ed Kaye is betting on custom CRISPR cures, and he's sitting down to talk through the science that made it possible and where Aurora is headed next.

CHOOSE YOUR PASS